| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $694.7M | +9.3% |
| Cost of Revenue | $323.3M | +5.6% |
| Gross Profit | $371.4M | +12.6% |
| R&D Expense | $132.0M | -17.5% |
| SG&A Expense | $108.7M | +10.6% |
| Operating Income | -$113.2M | +22.2% |
| Pre-tax Income | -$78.5M | +29.4% |
| Income Tax | $1.0M | -80.8% |
| Net Income | -$79.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $726.1M | +10.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $59.7M | -11.5% |
| Current Assets | $830.7M | -0.2% |
| Total Assets | $930.3M | +1.1% |
| Current Liabilities | $327.5M | +9.8% |
| Total Liabilities | $332.9M | +9.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $95.4M | +221.7% |
| Investing Cash Flow | $29.9M | -92.2% |
| Financing Cash Flow | -$54.9M | +30.7% |
| +31.8% |
| EPS (Basic) | -$0.51 | +33.8% |
| EPS (Diluted) | -$0.51 | +33.8% |
| Stockholders' Equity |
| $597.4M |
| -3.0% |